跳至主要内容
临床试验/NCT03525808
NCT03525808已完成不适用

A Multicenter, Single-arm Study of Endoscopic Ultrasound-Guided Drainage of Walled-off Pancreatic Necrosis With Lumen-Apposing Metal Stents

Boston Scientific Corporation10 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年9月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
10
主要终点
Number of Participants With Resolution of WON With Endoscopic Drainage

研究概览

简要总结

To demonstrate safety and effectiveness of lumen-apposing metal stents for resolution of walled off pancreatic necrosis (WONs) in patients with WONs with solid component >30%.

详细描述

This study is a prospective, single arm, multi-center trial. Treatment of up to 40 patients will take place at up to 6 clinical centers. Patients who meet all eligibility criteria will receive the AXIOS stent for up to 60 days stent indwell and 6 months follow-up after stent removal.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 22 and 75 years old
  • Severe or moderately severe acute necrotizing pancreatitis, defined per the 2012 Revised Atlanta Classification.
  • WON resulting from necrotizing pancreatitis per contrast-enhanced CT with the following characteristics, per the 2012 Revised Atlanta Classification:
  • Heterogeneous with liquid and non-liquid density with varying degrees of loculations (some may appear homogeneous)
  • Well defined wall
  • Location-intrapancreatic and/or extrapancreatic
  • Infected WON or symptomatic sterile WON Note: WON-related symptoms may include: pain, fever, leukocytosis, failure to thrive or deterioration of overall heath score, gastric outlet obstruction (GOO), weight loss, biliary obstructive symptoms, systemic inflammatory response syndrome (SIRS), deteriorating organ function, chronic nausea, lethargy, and inability to eat or gain weight
  • Imaging suggestive of greater than 30% necrotic material
  • WON ≥ 6cm in size
  • Eligible for endoscopic intervention
  • Acceptable candidate for endoscopic transluminal drainage
  • Patient understands the study requirements and the treatment procedures and provides written Informed Consent
  • Patient is willing to comply with all specified follow-up evaluations, including willingness to undergo a pre/post imaging study

排除标准

  • Pseudocyst
  • Cystic neoplasm
  • Untreated Pseudoaneurysm > 1cm within the WON
  • More than one WON clearly separated and requiring drainage
  • WONs that require dual modality interventions (endoscopic and percutaneous) from the beginning (i.e. deep paracolic space involvement that is inaccessible through the central drainage access)
  • Prior surgical, interventional radiology or endoscopic procedures for the treatment of the WON
  • Abnormal coagulation:
  • INR > 1.5 and not correctable
  • presence of a bleeding disorder
  • platelets < 50,000/mm3
  • Intervening gastric varices or unavoidable blood vessels within the access tract (visible using endoscopy or endoscopic ultrasound)
  • WON that poorly approximates the GI lumen (≥1cm away)
  • Pericolic gutter necrosis
  • Pelvic necrosis
  • Prior true anaphylactic reaction to contrast agents, nitinol (nickel titanium), silicone or any other materials contacting the patient
  • Female of childbearing potential with a positive pregnancy test prior to the procedure or intends to become pregnant during the study
  • Currently participating in another investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the endpoints of this study

结局指标

主要结局

Number of Participants With Resolution of WON With Endoscopic Drainage

时间窗: Up to 60 Days

Resolution of WON with endoscopic drainage defined as radiographic decrease of WON size to ≤ 3cm evaluated by CT scan or MRI

AXIOS Stent Related or WON Drainage Procedure Related Serious Adverse Events

时间窗: Through study completion, average of 8 months

AXIOS stent related or WON drainage procedure related serious adverse events

次要结局

  • Technical Success(Intraoperative (Stent placement))
  • Symptom Reduction(Through study completion, average of 8 months)
  • Time to WON Resolution(Up to 60 Days)
  • Stent Lumen Patency(Intraoperative (Stent placement through stent removal))
  • Incidence of New Organ Failure(Up to 60 days)
  • Resolution of WON: Radiographic Resolution Evaluated by MRI or CT(Through study completion, average of 8 months)
  • Drainage Procedural Time(Intraoperative (Stent placement))
  • WON Recurrence(Through study completion, average of 8 months)
  • Fluoroscopy(Intraoperative (Stent placement through stent removal))
  • Change in SF-12 Score(Difference from baseline to stent removal (up to 60 days) visit)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验